Caricamento...
Wixela Inhub: A Generic Equivalent Treatment Option for Patients with Asthma or COPD
PURPOSE: The purpose of this review is to discuss the development of Wixela™ Inhub™, a generic equivalent of Advair Diskus(®), a fixed-dose combination of fluticasone propionate/salmeterol powder for oral inhalation for patients with asthma whose symptoms are not controlled with inhaled corticostero...
Salvato in:
| Pubblicato in: | Pulm Ther |
|---|---|
| Autori principali: | , , , , , |
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Springer Healthcare
2020
|
| Soggetti: | |
| Accesso online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8137747/ https://ncbi.nlm.nih.gov/pubmed/33284384 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s41030-020-00142-5 |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !
|